United Kingdom · Question · Written question
UIN 199402
Diabetes: Drugs
Introduced
13 September 2023
Last action
20 September 2023 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
20 September 2023
Summary
To ask the Secretary of State for Health and Social Care, whether his Department is taking steps to ringfence the supply of glucagon-like peptide 1 agonists medication for patients with type 2 diabetes.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
13 September 2023
Written question
To ask the Secretary of State for Health and Social Care, whether his Department is taking steps to ringfence the supply of glucagon-like peptide 1 agonists medication for patients with type 2 diabetes.
Source: Commons
20 September 2023
Answer
We are aware of a supply issue with glucagon-like peptide-1 receptor agonists, which has been largely driven by off-label use for weight loss. We have issued guidance in the form of Medicine Supply Notifications and, on 18 July, issued a National Patient ...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2023-09-13/199402
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1660432
- uk · wq-1660432 · source updated 20 September 2023